Archives of Pharmacal Research

Papers
(The H4-Index of Archives of Pharmacal Research is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
Mouse models of nonalcoholic steatohepatitis and their application to new drug development173
Evaluation of bone health and fracture risk in type 2 diabetes: a network meta-analysis of anti-diabetic treatments versus placebo135
Renal tubular PAR2 promotes interstitial fibrosis by increasing inflammatory responses and EMT process99
Amyloidogenic, neuroinflammatory and memory dysfunction effects of HIV-1 gp12066
Ginsenoside-Rg2 exerts anti-cancer effects through ROS-mediated AMPK activation associated mitochondrial damage and oxidation in MCF-7 cells65
CD48-expressing non-small-cell lung cancer cells are susceptible to natural killer cell–mediated cytotoxicity60
Correction to: Recent advances in CRISPR technologies for genome editing54
Continuous TNF-α exposure in mammary epithelial cells promotes cancer phenotype acquisition via EGFR/TNFR2 activation52
Osteogenic effect of an adiponectin-derived short peptide that rebalances bone remodeling: a potential disease-modifying approach for postmenopausal osteoporosis therapy50
Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities48
Correction to: The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer45
Donepezil improves skeletal muscle insulin resistance in obese mice via the AMPK/FGF21-mediated suppression of inflammation and ferroptosis44
Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin41
Antibody-drug conjugates in cancer therapy: innovations, challenges, and future directions40
Challenges and opportunities of developing small-molecule therapies for age-related macular degeneration39
Retraction Note: Anti-inflammatory effect of atorvastatin on vascular reactivity and insulin resistance in fructose fed rats36
Impact of binge drinking on alcoholic liver disease36
Prenylated flavonoid fractions from Glycyrrhiza glabra alleviate insulin resistance in HepG2 cells by regulating the ERK/IRS-1 and PI3K/Akt signaling pathways35
Advances in plant-derived natural products for antitumor immunotherapy34
Regulation of NOX/p38 MAPK/PPARα pathways and miR-155 expression by boswellic acids reduces hepatic injury in experimentally-induced alcoholic liver disease mouse model: novel mechanistic insight33
Myriocin suppresses tumor growth by modulating macrophage polarization and function through the PI3K/Akt/mTOR pathway33
The role and application of transcriptional repressors in cancer treatment32
Minor structural changes, major functional impacts: posttranslational modifications and drug targets31
A review on bacteria-derived antioxidant metabolites: their production, purification, characterization, potential applications, and limitations30
Recent advances on Pestalotiopsis genus: chemistry, biological activities, structure–activity relationship, and biosynthesis30
Non-alcoholic fatty liver disease and liver secretome29
Isolation, structure elucidation, total synthesis, and biosynthesis of dermazolium A, an antibacterial imidazolium metabolite of a vaginal bacterium Dermabacter vaginalis29
Effects of fluconazole on the pharmacokinetics of celecoxib and its carboxylic acid metabolite in different CYP2C9 genotypes28
Naringin promotes fat browning mediated by UCP1 activation via the AMPK signaling pathway in 3T3-L1 adipocytes28
0.03213095664978